Clinical Trial Update: Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing reduced radiotherapy with paclitaxel/cisplatin vs standard radiotherapy with 5-fluorouracil/cisplatin in locally advanced head and neck …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Head and Neck Cancer | Phase 3 | Status: TERMINATED